Central African Republic vs Sri Lanka: Access to anti-retroviral drugs, female
Central African Republic
73.0%
in 2024
Sri Lanka
73.0%
in 2024
Central African Republic rank
71st
Sri Lanka rank
71st
Access to anti-retroviral drugs, female over time
- Central African Republic
- Sri Lanka
How they compare
Central African Republic currently reports 73.0% against 73.0% in Sri Lanka, a difference of 0.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Sri Lanka ahead.
Central African Republic ranks 71st and Sri Lanka ranks 71st of 141 countries.
Central African Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central African Republic | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.4% | 2.2% | 0.2% | Central African Republic |
| 2010s | 26.1% | 23.9% | 2.2% | Central African Republic |
| 2020s | 65.6% | 60.4% | 5.2% | Central African Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Central African Republic or Sri Lanka?
- Central African Republic, at 73.0% against 73.0% in Sri Lanka as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Central African Republic and Sri Lanka?
- 0.0%, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Sri Lanka?
- 25 years are reported by both, from 2000 to 2024.
- How do Central African Republic and Sri Lanka rank globally for access to anti-retroviral drugs, female?
- Central African Republic ranks 71st and Sri Lanka ranks 71st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.